Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism
Open accessPublished version of a preprint
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor 1α is a key regulator of the hypoxia response in normal and cancer tissues. It is well recognized to regulate glycolysis and is a target for therapy. However, how tumor cells adapt to grow in the absence of HIF1α is poorly understood and an important concept to understand for developing targeted therapies is the flexibility of the metabolic response to hypoxia via alternative pathways. We analyzed pathways that allow cells to survive hypoxic stress in the absence of HIF1α, using the HCT116 colon cancer cell line with deleted HIF1α versus control. Spheroids were used to provide a 3D model of metabolic gradients. We conducted a metabolomic, transcriptomic, and proteomic analysis and integrated the results. These showed surprisingly that in three-dimensional growth, a key regulatory step of glycolysis is Aldolase A rather than phosphofructokinase. Furthermore, glucose uptake could be maintained in hypoxia through upregulation of GLUT14, not previously recognized in this role. Finally, there was a marked adaptation and change of phosphocreatine energy pathways, which made the cells susceptible to inhibition of creatine metabolism in hypoxic conditions. Overall, our studies show a complex adaptation to hypoxia that can bypass HIF1α, but it is targetable and it provides new insight into the key metabolic pathways involved in cancer growth. Implications: Under hypoxia and HIF1 blockade, cancer cells adapt their energy metabolism via upregulation of the GLUT14 glucose transporter and creatine metabolism providing new avenues for drug targeting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was an accumulation of glycolytic intermediates, with a block of conversion of fructose-1,6-bisphosphate (Fru-1,6-BP) to dihydroxyacetone phosphate (DHAP) at the level of aldolase [58] rather than the earlier step of conversion of fructose-6-phosphate (Fru-6P) to Fru-1,6BP by PFK observed in c4 cells and tumors [16].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [58]
In the citing paper
“Valli et al. found that hypoxic HCT116 colorectal cancer cells were able to adapt to HIF-1α deletion via HIF-1-independent metabolic pathways [58].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [58]
In the citing paper
“This depletion of phosphocreatine reserves by CKB inhibition reduced the ability of the cancer cells to form metastatic outgrowths, a reflection of their ability to survive hypoxic environments.”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [58]
In the citing paper
“HIF-1α knockout HCT116 cells and spheroids were found to have higher levels of the cytoplasmic creatine kinase isoenzyme (creatine kinase B, CKB) but a lower level of the mitochondrial creatine kinase isoenzyme [58].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [58]
In the citing paper
“Targeting creatine metabolism by genetic silencing or pharmacological inhibition of CKB was found to greatly reduce the clonogenic potential and 3D cell spheroid growth of HIF-1 knockout cells under hypoxia compared to wild type controls [58].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [58]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · cited 3×
“Metabolic flexibility is acquired through genetic and nongenetic factors that allow tumors to grow in altered biochemical conditions such as hypoxia, acidic pH, and a nutrient-poor microenvironment (1).”
BackgroundInfluentialThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 10×
“org Mol Cancer Res; 17(7) July 2019 1537”
BackgroundInfluentialThe metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · cited 1×
“Warburg first described the increase of oxidation of glucose into lactate in cancer cells (2).”
BackgroundKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“Under hypoxic conditions, HIF1adrives phosphorylation of PDK that inhibits PDH and shunts Pyr away from mitochondria to lactate, reducing the rate of oxidative decarboxylation and diminishing acetyl-CoA formation (36).”
BackgroundReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · cited 1×
“In such conditions, citrate biosynthesis is prevented, reductive carboxylation is enhanced, and a HIF1a-dependent mechanism allows hypoxic cells to metabolize glutamine into fatty acids trough citrate formation (37).”
BackgroundCooperation and Competition in the Evolution of ATP-Producing Pathways
Pfeiffer, T., Schuster, S., & Bonhoeffer, S. (2001) · Science · doi:10.1126/science.1058079 · Cited by 1,354 · cited 1×
“Although yielding less ATP than OXPHOS, glycolysis is utilized predominantly by cancer cells and provides a more rapid response to the high energy demand of rapidly proliferating cancer cells (3).”
BackgroundHow cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Self-citationA Creatine-Driven Substrate Cycle Enhances Energy Expenditure and Thermogenesis in Beige Fat
Kazak, L., Chouchani, E. T., Jedrychowski, M. P., Erickson, B. K., Shinoda, K., Cohen, P., Vetrivelan, R., Lu, G. Z., Laznik-Bogoslavski, D., Hasenfuss, S. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.035 · Cited by 787 · cited 1×
“However, ATP maintenance is a process linked to ATP re/ generating metabolic systems that relies on biochemical regulatory systems at subcellular level (42).”
BackgroundMetabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710 · cited 2×
“Because of the high affinity for Glu, GTR3 overexpression could provide growth advantages in tumors already at lowGlu levels (18).”
Background
Cited by
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169
“Another interesting issue is that the upregulation of glucose transport by induction of GLUT14 that was observed by Valli et al. (2019) involved the activation of HIF-2 [58].”
BackgroundGut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence
Vacante, M., Ciuni, R., Basile, F., & Biondi, A. (2020) · Biomedicines · doi:10.3390/biomedicines8110489 · Cited by 106
Pan, T., Liu, J., Xu, S., Yu, Q., Wang, H., Sun, H., Wu, J., Zhu, Y., Zhou, J., & Zhu, Y. (2019) · Theranostics · doi:10.7150/thno.37472 · Cited by 96
“GLUT14 is a variant of GLUT3, and enhanced expression of GLUT14 has been reported in hypoxic CRC cells [42].”
BackgroundThe Liquid Biopsy in the Management of Colorectal Cancer: An Overview
Vacante, M., Ciuni, R., Basile, F., & Biondi, A. (2020) · Biomedicines · doi:10.3390/biomedicines8090308 · Cited by 79
“From a clinical point of view, GLCC1 was associated with carcinogenesis, tumor volume and poor prognosis in CRC patients [59,94].”
BackgroundLi, Q., Liu, M., Sun, Y., Jin, T., Zhu, P., Wan, X., Hou, Y., & Tu, G. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01933-7 · Cited by 56
“For instance, HCT116 colon cancer cells upregulated creatine metabolism to stabilize cellular ATP levels for survival in response to hypoxia and HIF1 blockade [41].”
Background
Metadata
- Authors
- Valli, A., Morotti, M., Zois, C. E., Albers, P. K., Soga, T., Feldinger, K., Fischer, R., Frejno, M., McIntyre, A., Bridges, E., Haider, S., Buffa, F. M., Baban, D., Rodriguez, M., Yanes, O., Whittington, H. J., Lake, H. A., Zervou, S., Lygate, C. A., Kessler, B. M., & Harris, A. L.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- Keio University (JP)
- 2Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- 5Metabolomics Platform, IISPV, Department of Electronic Engineering, Universitat Rovira i Virgili, Tarragona, Spain.
- Corresponding author
- Valli, Alessandro
- ORCID
- Venue
- Molecular Cancer Research
- Published
- 2019-07-01
- Volume
- 17
- Issue
- 7
- Pages
- 1531-1544
- ISSN
- 1541-7786 (ISSN-L)
- 1557-3125
- OpenAlex
- W2922448726
- Cited by
- 27
- References
- 49
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 1 · 2022: 2 · 2021: 10 · 2020: 5 · 2019: 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- Molecular Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Rovira & Virgili repository (submittedVersion, cc-by)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-sa)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Archivio istituzionale della Ricerca - Bocconi (submittedVersion)
- Funders
- Cancer Research UKCancer Research UK (CRUK) (C602/A18974)
- British Heart FoundationBritish Heart Foundation (BHF) (RG/13/8/30266)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- tumor hypoxia, creatine metabolism, phosphocreatine, aldolase A, glycolysis, glucose uptake, HCT116 cells, tumor spheroids, metabolic gradients, targeted drug delivery
- MeSH terms
- Tumor Hypoxia, Colonic Neoplasms, Creatine, Energy Metabolism, Fructose-Bisphosphate Aldolase, Glucose, Glycolysis, Humans, Spheroids, Cellular, HCT116 Cells, Glucose Transport Proteins, Facilitative, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-18-0315
- The paper
- Valli, A., Morotti, M., Zois, C. E., Albers, P. K., Soga, T., Feldinger, K., Fischer, R., Frejno, M., McIntyre, A., Bridges, E., Haider, S., Buffa, F. M., Baban, D., Rodriguez, M., Yanes, O., Whittington, H. J., Lake, H. A., Zervou, S., Lygate, C. A., . . . Harris, A. L. (2019). Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-18-0315
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.